Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prevention of clinically manifest rheumatoid arthritis by B cell directed therapy in the earliest phase of the disease
2009-010955-29Phase 4Active
- Sponsor
- AMC Health
- Start
- Feb 2009
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in rheumatoid arthritis (RA) comparing Rituximab with Placebo (2 arms). Primary endpoint: Development of clinically manifest arthritis. Started Feb 2009; status: active.
02
Drugs
rituximab
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on 2009-010955-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010955-29.